To answer this question we looked at the expression of genes involved in tumor resistance and identified CDKN1A as a gene overexpressed in both TSC2−/− AML organoids and kidney AML compared to control organoids and to normal kidney (Fig. 7a). Here, CDKN1A is linked to acute myeloid leukemia.